These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 36647796)

  • 1. Role of epigenetics in pancreatic ductal adenocarcinoma.
    Pandey S; Gupta VK; Lavania SP
    Epigenomics; 2023 Jan; 15(2):89-110. PubMed ID: 36647796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
    Eyres M; Lanfredini S; Xu H; Burns A; Blake A; Willenbrock F; Goldin R; Hughes D; Hughes S; Thapa A; Vavoulis D; Hubert A; D'Costa Z; Sabbagh A; Abraham AG; Blancher C; Jones S; Verrill C; Silva M; Soonawalla Z; Maughan T; Schuh A; Mukherjee S; O'Neill E
    Gastroenterology; 2021 Aug; 161(2):653-668.e16. PubMed ID: 33915173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma.
    Syren P; Andersson R; Bauden M; Ansari D
    Scand J Gastroenterol; 2017; 52(6-7):668-673. PubMed ID: 28301276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Analysis of the Aberrant Epigenetic Alteration of Pancreatic Ductal Adenocarcinoma.
    Xu R; Xu Q; Huang G; Yin X; Zhu J; Peng Y; Song J
    Biomed Res Int; 2019; 2019():9379864. PubMed ID: 31956659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
    Ciernikova S; Earl J; García Bermejo ML; Stevurkova V; Carrato A; Smolkova B
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes.
    Lomberk G; Blum Y; Nicolle R; Nair A; Gaonkar KS; Marisa L; Mathison A; Sun Z; Yan H; Elarouci N; Armenoult L; Ayadi M; Ordog T; Lee JH; Oliver G; Klee E; Moutardier V; Gayet O; Bian B; Duconseil P; Gilabert M; Bigonnet M; Garcia S; Turrini O; Delpero JR; Giovannini M; Grandval P; Gasmi M; Secq V; De Reyniès A; Dusetti N; Iovanna J; Urrutia R
    Nat Commun; 2018 May; 9(1):1978. PubMed ID: 29773832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis.
    Hara Y; Mizukami H; Yamazaki K; Yamada T; Igawa A; Takeuchi Y; Sasaki T; Kushibiki H; Murakami K; Kudoh K; Ishido K; Hakamada K
    J Pathol Clin Res; 2023 Sep; 9(5):354-366. PubMed ID: 37246239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Alterations in Pancreatic Cancer Metastasis.
    Wang SS; Xu J; Ji KY; Hwang CI
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex.
    Jamali M; Barar E; Shi J
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
    Hessmann E; Johnsen SA; Siveke JT; Ellenrieder V
    Gut; 2017 Jan; 66(1):168-179. PubMed ID: 27811314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
    Mardin WA; Haier J; Mees ST
    BMC Cancer; 2013 May; 13():264. PubMed ID: 23718921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
    Chandana S; Babiker HM; Mahadevan D
    Expert Opin Investig Drugs; 2019 Feb; 28(2):161-177. PubMed ID: 30539678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.
    Elrakaybi A; Ruess DA; Lübbert M; Quante M; Becker H
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
    Endo Y; Fujimoto M; Ito N; Takahashi Y; Kitago M; Gotoh M; Hiraoka N; Yoshida T; Kitagawa Y; Kanai Y; Arai E
    J Cancer Res Clin Oncol; 2021 May; 147(5):1341-1354. PubMed ID: 33635431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.
    Wang HC; Shih HY; Wu CC; Chen LT; Luo CW; Liu YC; Du JS; Huang MC; Su YY; Chen HD; Hsiao HH; Moi SH; Pan MR
    Int J Med Sci; 2022; 19(10):1615-1627. PubMed ID: 36185333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Cancer: Genetic Conditions and Epigenetic Alterations.
    Montalvo-Javé EE; Nuño-Lámbarri N; López-Sánchez GN; Ayala-Moreno EA; Gutierrez-Reyes G; Beane J; Pawlik TM
    J Gastrointest Surg; 2023 May; 27(5):1001-1010. PubMed ID: 36749558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.